Bromide

Bromide

SCHEMBL2769665

CCN(CCn1cc[n+](C)c1)c1ccc(N=Nc2nc3c([N+](=O)[O-])cc([N+](=O)[O-])cc3s2)cc1.[Br-]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
MAPK1 P28482 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
NPC1 O15118 1/20 0.35
ALPL P05186 1/20 0.35
ALPI P09923 1/20 0.35
ALPG P10696 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
THRB P10828 1/20 0.32
PTBP1 P26599 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2770872 1.00 MAPT (0.35) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1
SCHEMBL2786849 0.99 MAPT (0.36) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1
SCHEMBL2786846 0.99 MAPT (0.36) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1
Bromide SCHEMBL2769766 0.88 MAPT (0.39) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1
Bromide SCHEMBL2769769 0.88 MAPT (0.39) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1
SCHEMBL2770269 0.87 MAPT (0.39) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1
SCHEMBL2770268 0.87 MAPT (0.39) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1
Bromide SCHEMBL2770156 0.87 MAPT (0.37) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1
Bromide SCHEMBL2771594 0.87 MAPT (0.37) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1
SCHEMBL2769482 0.86 MAPT (0.37) MAPTL3MBTL1MAPK1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1825883-B1 Agents for coloring keratin fibers PROCTER & GAMBLE (US) 2010-04-14 EP claimed
US-7658770-B2 Agents for coloring keratin fibers THE PROCTER & GAMBLE COMPANY (US) 2010-02-09 US claimed
US-20090165221-A1 Agents for Coloring Keratin Fibers WELLA OPERATIONS US, LLC 2009-07-02 US claimed
US-7513916-B2 Agents for coloring keratin fibers THE PROCTER & GAMBLE COMPANY (US) 2009-04-07 US claimed
WO-2007097930-A1 AGENTS FOR COLORING KERATIN FIBERS THE PROCTER & GAMBLE COMPANY (US) 2007-08-30 WO claimed
US-20070199160-A1 Agents for coloring keratin fibers THE PROCTER & GAMBLE COMPANY 2007-08-30 US claimed
EP-1825883-A1 Agents for coloring keratin fibers Wella Aktiengesellschaft (DE) 2007-08-29 EP claimed
EP-1820537-A1 Agents for coloring keratin fibers Wella Aktiengesellschaft (DE) 2007-08-22 EP claimed
EP-1825883-B1 Agents for coloring keratin fibers PROCTER & GAMBLE (US) 2010-04-14 EP disclosed
US-7658770-B2 Agents for coloring keratin fibers THE PROCTER & GAMBLE COMPANY (US) 2010-02-09 US disclosed
US-20090165221-A1 Agents for Coloring Keratin Fibers WELLA OPERATIONS US, LLC 2009-07-02 US disclosed
US-7513916-B2 Agents for coloring keratin fibers THE PROCTER & GAMBLE COMPANY (US) 2009-04-07 US disclosed
US-20070199160-A1 Agents for coloring keratin fibers THE PROCTER & GAMBLE COMPANY 2007-08-30 US disclosed
EP-1825883-A1 Agents for coloring keratin fibers Wella Aktiengesellschaft (DE) 2007-08-29 EP disclosed
EP-1820537-A1 Agents for coloring keratin fibers Wella Aktiengesellschaft (DE) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090165221-A1 Agents for Coloring Keratin Fibers KRT18, IK, KRTCAP2 MAPT 781/4885L3MBTL1 4832/4885MAPK1 1043/4885
US-20070199160-A1 Agents for coloring keratin fibers KRT18, IK, KRTCAP2 MAPT 781/4885L3MBTL1 4832/4885MAPK1 1043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.